|
| Status |
Public on Aug 03, 2023 |
| Title |
Androgen Receptor is a Determinant of Melanoma BRAFi/MEKi Resistance |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
37838724 |
| Submission date |
May 17, 2023 |
| Last update date |
Oct 26, 2023 |
| Contact name |
Paola Ostano |
| Organization name |
Fondazione Edo ed Elvo Tempia
|
| Street address |
via Malta 3
|
| City |
Biella |
| ZIP/Postal code |
13900 |
| Country |
Italy |
| |
|
| Platforms (2) |
| GPL23126 |
[Clariom_D_Human] Affymetrix Human Clariom D Assay [transcript (gene) version] |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (28)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE199405 |
Androgen Receptor is a Determinant of Melanoma BRAFi/MEKi Resistance [Clariom_1] |
| GSE232690 |
Androgen Receptor is a Determinant of Melanoma BRAFi/MEKi Resistance [ChIP-Seq] |
| GSE232693 |
Androgen Receptor is a Determinant of Melanoma BRAFi/MEKi Resistance [Clariom_2] |
|
| Relations |
| BioProject |
PRJNA973589 |
Less...
More...